Skip to main content
Apellis Pharmaceuticals, Inc. (APLS)
May 14, 2026 - APLS was delisted (reason: acquired by BIIB)
41.03
-0.03 (-0.07%)
Inactive · Last trade price on May 13, 2026

Apellis Pharmaceuticals Employees

As of December 31, 2025, Apellis Pharmaceuticals had 739 total employees, including 733 full-time and 6 part-time employees. The number of employees increased by 29 or 4.08% compared to the previous year.

Employees
739
Change (1Y)
29
Growth (1Y)
4.08%
Revenue / Employee
$1,495,643
Profits / Employee
$180,337
Market Cap
5.25B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025739294.08%
Dec 31, 202471040.57%
Dec 31, 2023706-61-7.95%
Dec 31, 202276729161.13%
Dec 31, 202147610227.27%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

APLS News

More News